VCEL Q3 2025 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena

VCELVericel Corporation

$2B

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$68M+16.6% YoY

Gross Profit

$50M73.5% margin

Operating Income

$3M5.1% margin

Net Income

$5M7.5% margin

EPS (Diluted)

$0.10

QoQ Revenue Growth

+6.7%

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

$19M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$453M

Total Liabilities

$131M

Stockholders' Equity

$322M

Cash & Equivalents

$100M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$68M	$58M	+16.6%
Gross Profit	$50M	$42M	+19.0%
Operating Income	$3M	-$2M	+240.0%
Net Income	$5M	-$901,000	+663.2%

Revenue Segments

MACI Implants And Kits

$56M100%